19 results about "Sinusitis" patented technology

The application discloses an ear-nose-throat department rhinitis and rhinosinusitis nasal cavity flushing device, and belongs to the technical field of medical instruments, which comprises a flushing liquid injection mechanism and an inner-outer cannula breathing mechanism which are used in cooperation, wherein the flushing liquid injection mechanism comprises a liquid storage bag and a first conducting pipe, the first conducting pipe is connected with the liquid storage bag through a liquid delivery pipe, a nasal cavity liquid supply assembly and a nasal cavity foreign matter cleaning assembly are arranged on the first conducting pipe, and the nasal cavity liquid supply assembly is used in cooperation with the liquid delivery pipe; the inner-outer cannula breathing mechanism comprises a second conducting pipe, and a flushing liquid discharge assembly and a positioning assembly are arranged on the second conducting pipe; through the arrangement of the flushing liquid injection mechanism and the inner-outer cannula breathing mechanism, the device can effectively clean the nasal cavity of a patient, meets the demand of different cleaning modes, and has the characteristics of good cleaning effect, simple and convenient use and low manufacturing cost.

The present invention relates to a patch (1) for the topical treatment of sinusitis in a person to be treated, the patch (1) comprising at least one active section (2) with at least one active ingredient and at least one adhesive section (3), wherein the patch (1) is designed to be at least partially, preferably completely, occlusive in the at least one active section (2) and / or in the at least one adhesive section (3), wherein it is provided according to the invention that the at least one active section (2) contains a therapeutically effective amount of a non-steroidal anti-inflammatory drug and / or its physiologically compatible compounds / salts and / or physiologically compatible chemical derivatives as the at least one active ingredient, and that the patch (1) has a shape that is adapted to the anatomical conditions of the application site, wherein the application site is in the face in the area of ​​at least one of the paranasal sinuses,preferably located in the area of ​​the cheek of the person to be treated, in order to enable targeted percutaneous treatment of the sinusitis.

The invention provides magnolia denudata compound essential oil as well as a preparation method and application thereof, and the magnolia denudata compound essential oil comprises the following components in parts by mass: 30-40% of magnolia denudata essential oil, 15-20% of peppermint oil, 5-10% of fructus forsythiae oil, 8-10% of radix angelicae oil, 5-8% of radix saposhnikoviae oil, 5-8% of eucalyptus oil, 5-8% of ligusticum wallichii oil, 5-10% of lavender oil and 5-10% of agastache rugosus. The total percentage is 100%. The product provided by the invention can be applied to nasal products such as snorting, nasal stickers and nasal cleaning rods, relieving poor breath caused by acute nasosinusitis, nasal obstruction and headache caused by cold, relieving pressure and anxiety, refreshing and the like. The traditional Chinese medicine composition is extracted from pure plants, has no adverse reaction, can relieve poor breath caused by acute nasosinusitis and nasal obstruction and headache caused by cold at the same time, can relieve pressure and anxiety, and can refresh mind and restore consciousness.

A method for treating a narrowed region of a lumen in a patient's ear or nose is described herein. The method includes advancing a catheter within the lumen such that a distal end of the catheter is positioned proximate the narrowed region, filling a fillable member to cause the fillable member to expand within the lumen, and generating at least one shockwave from at least one shockwave emitter. The at least one shockwave creates one or more fractures in a bone structure of the narrowed region of the lumen that causes the narrowed region to expand.

This invention relates to the application of a traditional Chinese medicine composition in the preparation of a drug for sinusitis. The composition is characterized by being prepared from ephedra (processed with honey), bitter almond, perilla seed, prepared pinellia, licorice, scutellaria, angelica, belamcanda, coltsfoot flower, mulberry bark, cicada slough, silkworm, and earthworm. The composition of this invention improves sinusitis symptoms, reduces inflammation levels, and regulates the pH of nasal secretions in a sinusitis model prepared by Staphylococcus aureus, suggesting that this traditional Chinese medicine composition has a good therapeutic effect on sinusitis.

This invention relates to an antisense oligonucleotide targeting the interleukin-4 receptor and its applications. The antisense oligonucleotide (ASO) molecule is 16-22 bases in length and specifically pairs with a specific region of the target gene (interleukin-4 receptor). The ASO is used to treat diseases related to IL-4Rα, including but not limited to asthma (including eosinophilic types), atopic dermatitis, eosinophilic esophagitis, sinusitis, nasal polyps, nodular prurigo, urticaria, COPD, bullous pemphigoid, pruritus, and gastritis.

A composition comprising isolated Streptococcus pyogenes extracellular vesicles (EVs) suspended in a vehicle, for use in eliciting an adaptive immune response against group A streptococcus (GAS) in a subject. The EVs may comprise antigens MtsA, Spy_1228, PrsA1, PrsA2, SPy_0319 and / or GlnP. A composition comprising isolated S. pyogenes protein(s) MtsA, SPy_1228, PrsA1, PrsA2, GlnP, SPy_0319 and / or MalX. The compositions may be used for inducing protective immunity in a subject against a GAS infection, such as streptococcal pharyngitis, scarlet fever, impetigo, streptococcal meningitis, streptococcal sinusitis, necrotizing fasciitis, cellulitis, streptococcal toxic shock syndrome, rheumatic fever and post-streptococcal glomerulonephritis.

This invention is a high-potency medicinal oil composition and industrial processing method designed to prevent and treat acute and chronic respiratory tract infections, including sinusitis and tonsillitis, in a manner that breaks down the drug-resistant properties of pathogens (Antimicrobial A89. የ65ራርት1ረሰ6). The invention has a well-established framework for producing a precise 1 liter (1000 ML) pure liquid product with consistent quality.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a traditional Chinese medicine composition for treating chronic rhinitis-sinusitis, its preparation method, and its uses. The traditional Chinese medicine composition is made from Codonopsis pilosula, Astragalus membranaceus (processed), Atractylodes macrocephala (processed), Ligustrum lucidum, Magnolia biondii, Xanthium sibiricum (processed), Angelica dahurica, Ligusticum chuanxiong (processed), Platycodon grandiflorus, Cinnamomum cassia, Saposhnikovia divaricata, Glycyrrhiza uralensis (processed), and Asarum heterotropoides. This traditional Chinese medicine composition has the effects of clearing the lungs and dispelling pathogens, strengthening the spleen and replenishing qi, and draining pus and opening the nasal passages, showing significant therapeutic effects on chronic rhinitis-sinusitis. Furthermore, the preparation method of this traditional Chinese medicine composition has the advantages of simple preparation process, high efficiency, energy saving, and minimal destruction of effective components.

The invention discloses a traditional Chinese medicine composition for treating rhinitis and nasosinusitis and a preparation thereof, and relates to the technical field of traditional Chinese medicine preparations, and the traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 3-5 parts of honeysuckle, 1-3 parts of ginseng, 1-3 parts of radix angelicae, 0.5-2 parts of ligusticum wallichii, 0.5-2 parts of salvia miltiorrhiza, 0.5-2 parts of magnolia flower, 0.5-2 parts of rhizoma zingiberis, 0.5-2 parts of divaricate saposhnikovia root and 0.5-2 parts of ephedra. Through a synergistic effect mechanism of oral administration and external use, a new choice is provided for treatment of rhinitis and nasosinusitis. All the medicinal materials in the oral composition are reasonable in compatibility, and common symptoms such as nasal obstruction and runny nose can be relieved; the external preparation can directly act on local nasal cavity, and the mild preparation form is beneficial for patients to accept and use for a long time.

This invention provides a method for preparing a thermosensitive gel for the prevention and treatment of nasal diseases and its application. By weight and volume percentage, it comprises recombinant human type III collagen, mussel adhesive protein, an anti-allergy agent, traditional Chinese medicine extracts, thermosensitive materials, and a sodium pyruvate-cocamidopropyl betaine ion-pair complex. This invention, by pre-forming the ion-pair complex, simultaneously solves the technical problems of existing nasal gels, such as poor anti-dilution ability, short adhesion time, and easy inactivation of active ingredients. The product is liquid below 30°C and can be sprayed for complete nasal coverage. At body temperature, it transforms into a gel within 2 minutes for long-lasting adhesion, exhibiting rapid anti-inflammatory, nasal patency-clearing, antipruritic, and mucosal repair effects. It is suitable for the prevention and treatment of allergic rhinitis and sinusitis, as well as nasal wound care, with significantly better efficacy than similar commercially available products.

A set of antisense oligonucleotides specifically inhibiting thymic stromal lymphopoietin and the use thereof. The antisense oligonucleotide molecules have a length of 16-20 bases. The antisense oligonucleotide molecules have the following use: (1) in the preparation of a preparation for inhibiting the expression level of thymic stromal lymphopoietin; or (2) in the treatment of asthma, atopic dermatitis, chronic obstructive pulmonary disease, sinusitis, and nasal polyps.

Diagram "Algorithm for the diagnosis and treatment of post-implantation sinusitis that occurs after sinus lift and dental implantation"

This invention relates to a group of antisense oligonucleotides that specifically inhibit thymic stromal lymphopoietin and their applications. The antisense oligonucleotide molecules are 16-20 bases in length. This invention also relates to the following applications of the antisense oligonucleotide molecules (ASO): (1) preparing preparations that inhibit the expression of thymic stromal lymphopoietin; (2) treating asthma, atopic dermatitis, COPD, sinusitis and nasal polyps.

This invention discloses a method for constructing a sinusitis regulation analysis model based on nasal polyp cell inhibition data, belonging to the field of CRSwNP disease analysis technology. The method includes the following steps: collecting Lund-Kennedy scores and corresponding nasal polyp cell inhibition data from CRSwNP patients to obtain raw sample data; screening the raw sample data to remove unqualified raw sample data from CRSwNP patients to obtain standard sample data; performing index preprocessing based on the standard sample data and obtaining the optimal lag order to obtain reference sample data; constructing an LK analysis prediction model based on the reference sample data and analyzing and predicting the Lund-Kennedy scores of CRSwNP patients. This invention addresses the problem that existing CRSwNP disease analysis technologies cannot provide clinicians with objective and reliable analytical and predictive tools when analyzing and predicting the Lund-Kennedy scores of CRSwNP patients, thus failing to help clinicians reliably predict the disease progression of CRSwNP patients during treatment.

The application discloses a method for stereoscopic reconstruction and visualization of nasal polyp tissue based on artificial intelligence recognition of continuous pathological sections, which comprises the following steps: strict continuous section of a reconstruction object; HE staining of the continuous sections; affine registration of the continuous pathological sections; one-by-one analysis of the registered continuous pathological sections; stacking according to the registration sequence, then processing, to obtain three-dimensional model data of the nasal polyp tissue structure; and visual rendering of the three-dimensional model data of the nasal polyp tissue structure, combined with a preliminary stereoscopic model, to obtain a final stereoscopic model of the nasal polyp tissue structure. The method can reconstruct and visualize the nasal polyp tissue, and can show the three-dimensional structure of the distribution characteristics of inflammatory cells and tissue structure of the nasal polyp in the spatial structure, so that the morphological structure content of the nasal polyp tissue is enriched, and morphological basis is provided for further exploring the occurrence and development mechanism of chronic rhinosinusitis with nasal polyps.

The invention discloses a nasal cavity flushing device for rhinitis and nasosinusitis in the otolaryngology department, and belongs to the technical field of medical instruments.The nasal cavity flushing device comprises a flushing fluid injection mechanism and an inner and outer sleeve breathing mechanism which are used in cooperation, the flushing fluid injection mechanism comprises a fluid storage bag and a first communicating pipe, and the first communicating pipe is connected with the fluid storage bag through a fluid conveying pipe; a nasal cavity liquid feeding assembly and a nasal cavity foreign body cleaning assembly are arranged on the first conduction pipe, and the nasal cavity liquid feeding assembly is used in cooperation with the liquid feeding pipe; the inner and outer sleeve breathing mechanism comprises a second conduction pipe, and a flushing fluid discharge assembly and a positioning assembly which are arranged on the second conduction pipe; through the arrangement of the flushing fluid injection mechanism and the inner and outer sleeve breathing mechanism, the nasal cavity of a patient can be effectively cleaned, the requirements of different cleaning modes are met, and the nasal cavity cleaning device has the advantages of being good in cleaning effect, easy and convenient to use and low in manufacturing cost.

The invention relates to the technical field of medical instruments, in particular to a dynamic protection system for maxillary sinus perforation in an apical surgery, which comprises an air bag, the air bag is connected with an air inflation device, a negative pressure suction device and a water leakage sensing device are arranged on the outer side of the air bag, and the air inflation device, the negative pressure suction device and the water leakage sensing device are all electrically connected with a controller. The liquid leakage condition at the perforation position is monitored in real time through the water leakage sensing device, once a leakage signal is detected, the controller immediately instructs the negative pressure suction device to start and suck away liquid and instructs the air inflation device to supplement air at the same time, the size of the air bag is finely adjusted and increased, gaps generated due to tissue changes are compensated, and it is ensured that the air bag is continuously and tightly attached to the edge of the perforation. Oral liquid and infections are fundamentally prevented from entering the maxillary sinus, the clear and dry operation view is kept, hydrostatic pressure generated by liquid accumulation is prevented from damaging the sealing performance of the air bag, and the discomfort of a patient in an operation and the occurrence probability of postoperative maxillary sinusitis are greatly reduced.

A suspension formulation of clobetasol propionate nanoparticles is described. This suspension can be used therapeutically to treat burns of the skin and eyes, to promote wound healing, to prevent or reduce hypertrophic scarring / keloids, and to treat allergic rhinitis / sinusitis, asthma, inner ear disorders (including hearing loss, tinnitus, or dizziness), tenosynovitis, tendinitis, enthesitis, or arthritis.